HYPERION DEFI, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
HYPERION DEFI, INC. (HYPD) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 13.03 thousand shares for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2025-04-15
- HYPERION DEFI, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2023-09-30 was 926.23K shares.
- HYPERION DEFI, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2022-06-30 was 1.87M shares.
- HYPERION DEFI, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2022-03-31 was 1.87M shares.
- HYPERION DEFI, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2023 was 13.03K shares, a 96.09% decline from fiscal 2022.
- HYPERION DEFI, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2022 was 333.04K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | 13.03K shares 10-K · filed 2025-04-15 | 1.04M shares 10-K · filed 2024-03-18 | |||
| 2023-09-30 | 926.23K shares 10-Q · filed 2024-11-12 | 305.35K shares 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | 333.04K shares 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | 445.27K shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 1.87M shares 10-Q · filed 2023-08-11 | 671.59K shares 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | 1.87M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |